Schöpf E
Universitäts-Hautklinik der Albert-Ludwigs-Universität, Freiburg i. Br.
Infection. 1987;15 Suppl 5:S254-8. doi: 10.1007/BF01643199.
Like many other drugs co-trimoxazole can induce a large number of different skin reactions, mainly of allergic pathogenesis. The majority of these reactions, such as urticarial, purpuric, maculo-papular, and pustular exanthemas as well as photallergic reactions, generally do not endanger the life of the patient. Apart from very rare cases of anaphylactic shock, there is a risk of lethality associated with Stevens-Johnson syndrome and Lyell's syndrome of approximately 1% and 30%, respectively. Between 1981 and 1985, an extensive epidemiological survey was carried out in Germany which enabled approximation of drug induced severe skin reactions (Lyell's syndrome, Stevens-Johnson syndrome). Preliminary evaluation of the survey allowed the identification of 217 Lyell's syndromes and 296 Stevens-Johnson syndromes. The total registration rate resulting from an almost complete survey of all applicable medical units (dermatology, burns, intensive care) was 92%. The basic risk amongst the population of acquiring Lyell's syndrome and Stevens-Johnson syndrome, as calculated from the data gathered between 1981 and 1985, is 0.8 and 1.0 per year, and per one million inhabitants respectively, in the drug-related incidence calculation. Co-trimoxazole is in the upper third of the table of drugs which certainly, probably, or possibly induced a Lyell's syndrome and in the middle of the table of those that induced Stevens-Johnson syndrome.
与许多其他药物一样,复方新诺明可引发大量不同的皮肤反应,主要由过敏发病机制引起。这些反应中的大多数,如荨麻疹、紫癜、斑丘疹和脓疱性皮疹以及光过敏反应,一般不会危及患者生命。除了极罕见的过敏休克病例外,史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的致死风险分别约为1%和30%。1981年至1985年期间,德国开展了一项广泛的流行病学调查,以估算药物引起的严重皮肤反应(中毒性表皮坏死松解症、史蒂文斯-约翰逊综合征)情况。该调查的初步评估确定了217例中毒性表皮坏死松解症和296例史蒂文斯-约翰逊综合征。对所有适用医疗单位(皮肤科、烧伤科、重症监护科)几乎进行全面调查后的总登记率为92%。根据1981年至1985年收集的数据计算,在人群中患中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征的基本风险,在药物相关发病率计算中分别为每年每百万居民0.8例和1.0例。在肯定、很可能或可能引发中毒性表皮坏死松解症的药物列表中,复方新诺明位列前三分之一;在引发史蒂文斯-约翰逊综合征的药物列表中,复方新诺明位居中间。